In the spring, the U.S. government and the World Health Organization declared an end to the COVID-19 global health emergency.
US-China tensions persist; Genmab’s $1.8B ADC bet; New obesity startup in town; ALS drug withdrawal; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit